Angiotensin-receptor blockers in prevention of cardiovascular events: are they as effective as angiotensin-converting enzyme inhibitors?

被引：0
|
作者：
Teo, Koon K. [1 ]
机构：
[1] McMaster Univ, Med Ctr, Div Cardiol, Dept Med, Hamilton, ON L8N 3Z5, Canada
来源：
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2009年 / 119卷 / 1-2期
关键词：
VENTRICULAR SYSTOLIC FUNCTION; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; RANDOMIZED TRIAL; DYSFUNCTION; TELMISARTAN; CANDESARTAN; INTOLERANT; MORBIDITY; CAPTOPRIL;
D O I：
10.20452/pamw.590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 50 条
  • [1] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in prevention of nephropathy and cardiovascular disease in diabetics
    Al Tourah, Wehad H.
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2008, 2 (02) : 131 - 134
  • [2] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    [J]. ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [3] Role of Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in the prevention of progression of renal disease
    Ram C.V.S.
    Vergne-Marini P.
    [J]. Current Hypertension Reports, 1999, 1 (5) : 431 - 435
  • [4] Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in chronic heart failure
    McClellan, MB
    Loeb, JM
    Clancy, CM
    Francis, GS
    Jacobs, AK
    Kizer, KW
    O'Kane, ME
    Wolk, MJ
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (05) : 386 - 387
  • [5] Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
    Caldeira, Daniel
    David, Claudio
    Sampaio, Cristina
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 263 - 277
  • [6] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for the Prevention of Migraines
    Gales, Barry J.
    Bailey, Emilee K.
    Reed, Ashley N.
    Gales, Mark A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (02) : 360 - 366
  • [7] Abnormalities of bradykinin in angioedema due to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers
    Hosotte, M.
    Jarlot, S.
    Beaudouin, E.
    Morisset, M.
    Drouet, C.
    Kanny, G.
    [J]. ALLERGY, 2012, 67 : 501 - 501
  • [8] Combining angiotensin-receptor blockers with angiotensin-converting-enzyme inhibitors
    Phillips, Christopher O.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (06) : E309 - E311
  • [9] Efficacy of Aliskiren for Patients with Hypertension Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin-Receptor Blockers
    Fujino, Noboru
    Araki, Tsutomu
    Yasuda, Toshihiko
    Terai, Hidenobu
    Konno, Tetsuo
    Sakata, Kenji
    Hayashi, Kenshi
    Kawashiri, Masaaki
    Ino, Hidekazu
    Yamagishi, Masakazu
    [J]. JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S157 - S157
  • [10] Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors
    Walker, Alexander M.
    Liang, Caihua
    Clifford, C. Robin
    Parker, Crawford
    Feldman, Allen
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (04) : 348 - 356
12345